Read BioAge Labs Reports Early Success with Pill Targeting Heart Risk Inflammation LifeHealth BioAge Labs Reports Early Success with Pill Targeting Heart Risk Inflammation BioAge Labs has announced encouraging findings from an early study of its investigational pill designed to reduce cardiovascular risks by targeting inflammation. Editorial Staff 18 days ago